ETON Crosses Above Average Analyst Target
In recent trading, shares of Eton Pharmaceuticals Inc (Symbol: ETON) have crossed above the average analyst 12-month target price of $52.70, changing hands for $58.86/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrad
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.